5TMG
Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor
Summary for 5TMG
| Entry DOI | 10.2210/pdb5tmg/pdb |
| Related | 5TMK |
| Descriptor | Renin, 2-acetamido-2-deoxy-beta-D-glucopyranose, 5-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]-1-phenyl-1H-1,2,3-triazole-4-carboxamide, ... (7 entities in total) |
| Functional Keywords | protein-ligand complex, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| Biological source | Homo sapiens (Human) |
| Cellular location | Secreted: P00797 |
| Total number of polymer chains | 2 |
| Total formula weight | 76015.81 |
| Authors | Snell, G.P.,Behnke, C.A.,Okada, K.,Hideyuki, O.,Sang, B.C.,Lane, W. (deposition date: 2016-10-12, release date: 2017-10-18, Last modification date: 2024-10-09) |
| Primary citation | Tokuhara, H.,Imaeda, Y.,Fukase, Y.,Iwanaga, K.,Taya, N.,Watanabe, K.,Kanagawa, R.,Matsuda, K.,Kajimoto, Y.,Kusumoto, K.,Kondo, M.,Snell, G.P.,Behnke, C.A.,Kuroita, T. Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor To be published, |
| Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report






